Cargando…
Sphingosine kinase 2-deficiency mediated changes in spinal pain processing
Chronic pain is one of the most burdensome health issues facing the planet (as costly as diabetes and cancer combined), and in desperate need for new diagnostic targets leading to better therapies. The bioactive lipid sphingosine 1-phosphate (S1P) and its receptors have recently been shown to modula...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522551/ https://www.ncbi.nlm.nih.gov/pubmed/26283908 http://dx.doi.org/10.3389/fnmol.2015.00029 |
_version_ | 1782383964971859968 |
---|---|
author | Canlas, Jastrow Holt, Phillip Carroll, Alexander Rix, Shane Ryan, Paul Davies, Lorena Matusica, Dusan Pitson, Stuart M. Jessup, Claire F. Gibbins, Ian L. Haberberger, Rainer V. |
author_facet | Canlas, Jastrow Holt, Phillip Carroll, Alexander Rix, Shane Ryan, Paul Davies, Lorena Matusica, Dusan Pitson, Stuart M. Jessup, Claire F. Gibbins, Ian L. Haberberger, Rainer V. |
author_sort | Canlas, Jastrow |
collection | PubMed |
description | Chronic pain is one of the most burdensome health issues facing the planet (as costly as diabetes and cancer combined), and in desperate need for new diagnostic targets leading to better therapies. The bioactive lipid sphingosine 1-phosphate (S1P) and its receptors have recently been shown to modulate nociceptive signaling at the level of peripheral nociceptors and central neurons. However, the exact role of S1P generating enzymes, in particular sphingosine kinase 2 (Sphk2), in nociception remains unknown. We found that both sphingosine kinases, Sphk1 and Sphk2, were expressed in spinal cord (SC) with higher levels of Sphk2 mRNA compared to Sphk1. All three Sphk2 mRNA-isoforms were present with the Sphk2.1 mRNA showing the highest relative expression. Mice deficient in Sphk2 (Sphk2(−/−)) showed in contrast to mice deficient in Sphk1 (Sphk1(−/−)) substantially lower spinal S1P levels compared to wild-type C57BL/6 mice. In the formalin model of acute peripheral inflammatory pain, Sphk2(−/−) mice showed facilitation of nociceptive transmission during the late response, whereas responses to early acute pain, and the number of c-Fos immunoreactive dorsal horn neurons were not different between Sphk2(−/−) and wild-type mice. Chronic peripheral inflammation (CPI) caused a bilateral increase in mechanical sensitivity in Sphk2(−/−) mice. Additionally, CPI increased the relative mRNA expression of P(2)X(4) receptor, brain-derived neurotrophic factor and inducible nitric oxide synthase in the ipsilateral SC of wild-type but not Sphk2(−/−) mice. Similarly, Sphk2(−/−) mice showed in contrast to wild-type no CPI-dependent increase in areas of the dorsal horn immunoreactive for the microglia marker Iba-1 and the astrocyte marker Glial fibrillary acidic protein (GFAP). Our results suggest that the tightly regulated cell signaling enzyme Sphk2 may be a key component for facilitation of nociceptive circuits in the CNS leading to central sensitization and pain memory formation. |
format | Online Article Text |
id | pubmed-4522551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-45225512015-08-17 Sphingosine kinase 2-deficiency mediated changes in spinal pain processing Canlas, Jastrow Holt, Phillip Carroll, Alexander Rix, Shane Ryan, Paul Davies, Lorena Matusica, Dusan Pitson, Stuart M. Jessup, Claire F. Gibbins, Ian L. Haberberger, Rainer V. Front Mol Neurosci Neuroscience Chronic pain is one of the most burdensome health issues facing the planet (as costly as diabetes and cancer combined), and in desperate need for new diagnostic targets leading to better therapies. The bioactive lipid sphingosine 1-phosphate (S1P) and its receptors have recently been shown to modulate nociceptive signaling at the level of peripheral nociceptors and central neurons. However, the exact role of S1P generating enzymes, in particular sphingosine kinase 2 (Sphk2), in nociception remains unknown. We found that both sphingosine kinases, Sphk1 and Sphk2, were expressed in spinal cord (SC) with higher levels of Sphk2 mRNA compared to Sphk1. All three Sphk2 mRNA-isoforms were present with the Sphk2.1 mRNA showing the highest relative expression. Mice deficient in Sphk2 (Sphk2(−/−)) showed in contrast to mice deficient in Sphk1 (Sphk1(−/−)) substantially lower spinal S1P levels compared to wild-type C57BL/6 mice. In the formalin model of acute peripheral inflammatory pain, Sphk2(−/−) mice showed facilitation of nociceptive transmission during the late response, whereas responses to early acute pain, and the number of c-Fos immunoreactive dorsal horn neurons were not different between Sphk2(−/−) and wild-type mice. Chronic peripheral inflammation (CPI) caused a bilateral increase in mechanical sensitivity in Sphk2(−/−) mice. Additionally, CPI increased the relative mRNA expression of P(2)X(4) receptor, brain-derived neurotrophic factor and inducible nitric oxide synthase in the ipsilateral SC of wild-type but not Sphk2(−/−) mice. Similarly, Sphk2(−/−) mice showed in contrast to wild-type no CPI-dependent increase in areas of the dorsal horn immunoreactive for the microglia marker Iba-1 and the astrocyte marker Glial fibrillary acidic protein (GFAP). Our results suggest that the tightly regulated cell signaling enzyme Sphk2 may be a key component for facilitation of nociceptive circuits in the CNS leading to central sensitization and pain memory formation. Frontiers Media S.A. 2015-08-03 /pmc/articles/PMC4522551/ /pubmed/26283908 http://dx.doi.org/10.3389/fnmol.2015.00029 Text en Copyright © 2015 Canlas, Holt, Carroll, Rix, Ryan, Davies, Matusica, Pitson, Jessup, Gibbins and Haberberger. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Canlas, Jastrow Holt, Phillip Carroll, Alexander Rix, Shane Ryan, Paul Davies, Lorena Matusica, Dusan Pitson, Stuart M. Jessup, Claire F. Gibbins, Ian L. Haberberger, Rainer V. Sphingosine kinase 2-deficiency mediated changes in spinal pain processing |
title | Sphingosine kinase 2-deficiency mediated changes in spinal pain processing |
title_full | Sphingosine kinase 2-deficiency mediated changes in spinal pain processing |
title_fullStr | Sphingosine kinase 2-deficiency mediated changes in spinal pain processing |
title_full_unstemmed | Sphingosine kinase 2-deficiency mediated changes in spinal pain processing |
title_short | Sphingosine kinase 2-deficiency mediated changes in spinal pain processing |
title_sort | sphingosine kinase 2-deficiency mediated changes in spinal pain processing |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522551/ https://www.ncbi.nlm.nih.gov/pubmed/26283908 http://dx.doi.org/10.3389/fnmol.2015.00029 |
work_keys_str_mv | AT canlasjastrow sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT holtphillip sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT carrollalexander sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT rixshane sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT ryanpaul sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT davieslorena sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT matusicadusan sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT pitsonstuartm sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT jessupclairef sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT gibbinsianl sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing AT haberbergerrainerv sphingosinekinase2deficiencymediatedchangesinspinalpainprocessing |